Sarikidi, A.;                     Kefalakes, E.;                     Falk, C.S.;                     Esser, R.;                     Ganser, A.;                     Thau-Habermann, N.;                     Petri, S.    
        Altered Immunomodulatory Responses in the CX3CL1/CX3CR1 Axis Mediated by hMSCs in an Early In Vitro SOD1G93A Model of ALS. Biomedicines 2022, 10, 2916.
    https://doi.org/10.3390/biomedicines10112916
    AMA Style
    
                                Sarikidi A,                                 Kefalakes E,                                 Falk CS,                                 Esser R,                                 Ganser A,                                 Thau-Habermann N,                                 Petri S.        
                Altered Immunomodulatory Responses in the CX3CL1/CX3CR1 Axis Mediated by hMSCs in an Early In Vitro SOD1G93A Model of ALS. Biomedicines. 2022; 10(11):2916.
        https://doi.org/10.3390/biomedicines10112916
    
    Chicago/Turabian Style
    
                                Sarikidi, Anastasia,                                 Ekaterini Kefalakes,                                 Christine S. Falk,                                 Ruth Esser,                                 Arnold Ganser,                                 Nadine Thau-Habermann,                                 and Susanne Petri.        
                2022. "Altered Immunomodulatory Responses in the CX3CL1/CX3CR1 Axis Mediated by hMSCs in an Early In Vitro SOD1G93A Model of ALS" Biomedicines 10, no. 11: 2916.
        https://doi.org/10.3390/biomedicines10112916
    
    APA Style
    
                                Sarikidi, A.,                                 Kefalakes, E.,                                 Falk, C. S.,                                 Esser, R.,                                 Ganser, A.,                                 Thau-Habermann, N.,                                 & Petri, S.        
        
        (2022). Altered Immunomodulatory Responses in the CX3CL1/CX3CR1 Axis Mediated by hMSCs in an Early In Vitro SOD1G93A Model of ALS. Biomedicines, 10(11), 2916.
        https://doi.org/10.3390/biomedicines10112916